Study title:
"Shader-R-I, Pary-R-J, Harmatz-J-S, Allison-S, Locniskar-A,
Greenblatt-D-J.
Tufts Univ, New England Med Ctr, Dept Psychiat, Boston, Ma, 02111.
Tufts Univ, New England Med Ctr, Div Clin Pharmacol, Boston, Ma,
02111.
Plasma-Concentrations And Clinical Effects After Single Oral Doses Of
Prazepam, Clorazepate, And Diazepam.
Journal-Of-Clinical-Psychiatry, 1984, V45, N10, P411-413."
"Shader-R-I, Pary-R-J, Harmatz-J-S, Allison-S, Locniskar-A,
Greenblatt-D-J.
Tufts Univ, New England Med Ctr, Dept Psychiat, Boston, Ma, 02111.
Tufts Univ, New England Med Ctr, Div Clin Pharmacol, Boston, Ma,
02111.
Plasma-Concentrations And Clinical Effects After Single Oral Doses Of
Prazepam, Clorazepate, And Diazepam.
Journal-Of-Clinical-Psychiatry, 1984, V45, N10, ...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases
|
Brands: Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report |
Assessment: |
Active substance: PRAZEPAM |
ATC code: N05BA11
|
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|